MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • 2019 International Congress

    Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

    A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-­under­-Lyme, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…
  • 2019 International Congress

    Patterns of brain activity linked to Mild Behavioral Impairment in Parkinson’s disease

    EJ. Yoon, Z. Ismail, M. Kibreab, T. Hammer, J. Cheetham, I. Kathol, M. Ramezani, S. Lang, J. Sarna, D. Martino, S. Furtado, O. Monchi (Calgary, AB, Canada)

    Objective: To evaluate the association between Mild Behavioral Impairment (MBI) and pattern of brain activity during a set-shifting task in Parkinson’s disease (PD). Background: MBI…
  • 2019 International Congress

    The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

    B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

    Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…
  • 2019 International Congress

    Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

    K. Fifel, T. Deboer (Leiden, Netherlands)

    Objective: This study aims at investigating the impact of sleep and sleep deprivation on neuronal activity of midbrain dopaminergic areas and different subdivisions of the…
  • 2019 International Congress

    Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease

    S. Martinez-Horta, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore grey-matter volume (GMV) differences between early-stage Huntington's disease (HD) patients with and without significant irritability/aggression symptoms (IAs) and to assess it association…
  • 2019 International Congress

    Clinical and cognitive features of anxiety in Parkinson’s disease

    G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…
  • 2019 International Congress

    Progression of neuropsychiatric symptoms in Parkinson’s disease

    J. Dlay, G. Duncan, T. Khoo, C. Williams-Gray, D. Breen, R. Barker, D. Burn, R. Lawson, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the progression of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) and their associations with quality of life (QoL) and motor problems. Background:…
  • 2019 International Congress

    Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

    M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

    Objective: To find out the prevalence of different defence mechanism and coping strategies in the patients with PD.To find out the relationship between using of…
  • 2019 International Congress

    Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

    P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)

    Objective: The aims of this study was to determine the frequency of Dopamine agonist (DA) withdrawal syndrome (DAWS) in a sample of Sardinian patients with…
  • 2019 International Congress

    Expanding the Phenotype of KCNA2 Mutation: Tics and Stereotypies

    J. Legacy, M. Burns, A. Elkouzi, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To report a case of KCNA2 mutation variant with tics. Background: Mutations in the KCNA2 gene impact the function of a voltage-gated potassium channel…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley